Halozyme Therapeutics shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Halozyme Therapeutics by Ameriprise Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $17k | 18k | 0.95 |
2024-09-30 | $12M | 12M | 1.00 |
2024-03-31 | $14M | 15M | 0.88 |
2023-09-30 | $14M | 16M | 0.84 |
2023-06-30 | $14M | 16M | 0.83 |
2023-03-31 | $14M | 16M | 0.85 |
2022-12-31 | $14M | 14M | 0.97 |